VETERINARY CERTIFICATE

Embryos of domestic animals of the bovine species for imports collected or produced in accordance with Council Directive 89/556/EEC

1. Country of provenance and competent authority

2. Health certificate No

A. ORIGIN OF EMBRYOS

3. Approval number of the embryo collection team or embryo production team (1):

4. Name and address of the embryo collection team or embryo production team (1):

5. Name and address of the consignor

6. Country and place of loading

7. Means of transport

B. DESTINATION OF EMBRYOS

8. Member State of destination

9. Name and address of the consignee

C. IDENTIFICATION OF EMBRYOS

10.1. Identification mark of embryos (2)

10.2. Number of embryos

10.3. Produced embryos (1)

(a) Derived by in vitro fertilisation

(b) Subjected to penetration of zona pellucida

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

D. HEALTH INFORMATION

11. I, the undersigned official veterinarian of the Government of

(insert name of exporting country)

certify that:

11.1. the embryo collection (1)/production (1) team identified above:

is approved in accordance with Chapter I of Annex A to Directive 89/556/EEC,

carried out the collection, processing, or production and storing and transport of the embryos described above in accordance with Chapter II of Annex A to Directive 89/556/EEC,

is subjected at least twice per year to inspection by an official veterinarian.

11.2. The embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings:

11.2.1. has been free from rinderpest during 12 months immediately prior to the collection (1) or production (1) of the embryos;

11.2.2.1. either has been free from foot-and-mouth disease during the 12 months immediately prior to collection (1) or production (1) of the embryos and has not practised vaccination against foot-and-mouth disease during this period (1),

or

11.2.2.2. has not been free from foot-and-mouth disease for the 12 months immediately prior to the collection (1) or production (1) of the embryos and/or has practised vaccination against foot-and-mouth disease during this period, and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos come from a holding in which no animal has shown clinical signs of foot-and-mouth disease nor was vaccinated against foot-and-mouth disease during the 30 days prior to collection (1);

11.2.3.1. has been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection (1) or production (1) of the embryos to be exported and does not practise vaccination against them (1),

or

11.2.3.2. has not been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection (1) or production (1) of the embryos to be exported and/or practises vaccination against them, and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to an agar gel immuno-diffusion test and a serum neutralisation test for the detection of antibodies against the epizootic haemorrhagic disease virus carried out with negative results on a blood sample taken not less than 21 days following collection (1);

11.3.

11.3.1. the premises on which the embryos to be exported or the ovaries, oocytes and other tissues used in the production of embryos to be exported were collected and processed were at the time of collection situated in the centre of an area of 20 km diameter in which according to official findings there had been no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia for 30 days immediately prior to collection and in the case of embryos certified under 11.2.2.2 and 11.2.3.2 for 30 days after collection;

11.3.2. between the time of collection or production of the embryos to be exported and their dispatch, they were stored continuously in approved premises which were situated in the centre of an area of 20 km in diameter in which according to official findings there was no incidence of foot-and-mouth disease, contagious vesicular stomatitis or Rift Valley fever;

11.4. the donor females and donors of ovaries, oocytes and other tissues used in the production of embryos:

11.4.1. were located during the 30 days immediately prior to collection of the embryos to be exported in premises situated in the centre of an area of 20 km in diameter in which according to official findings there was no incidence of foot-and-mouth disease, blue tongue, epizootic haemorrhagic disease, contagious vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia during this period;

11.4.2. showed no clinical sign of disease on the day of collection;

11.4.3. have spent the six months immediately prior to collection in the territory of the exporting country in a maximum of two herds:

which, according to official findings, have been free from tuberculosis,

which, according to official findings, have been free from brucellosis,

which have been free from enzootic bovine leukosis or in which no animal has shown clinical signs of enzootic bovine leukosis during the previous three years,

in which no bovine animal has shown clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months.

11.5. The embryos comply with the following additional guarantees (3):

11.5.1. either the embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings is free of Akabane disease (1),

or

11.5.2. the embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings is not free of Akabane disease; and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to a serum neutralisation test for Akabane disease carried out with negative results on a blood sample taken not less than 21 days following collection (1).

11.6. The embryos to be exported were conceived as a result of artificial insemination or in vitro fertilisation with semen complying with the following requirements:

it was collected from donor sires standing at a semen collection centre approved by the competent authority for the collection, processing and storage of semen in accordance with Directive 88/407/EEC, and

it comes from semen collection or storage centres which are situated either in a Member State of the European Community or a third country and which are approved in accordance with Article 5(1) and Article 9(1) respectively of Directive 88/407/EEC (5).

E. VALIDITY

12. Date and place

13. Name and qualification of the official veterinarian

14. Signature and stamp of the official veterinarian (4)

Note for guidance:

(1) Delete as appropriate.

(2) Corresponding to the identification of the donor cows and date of collection.

(3) See the remarks for the exporting country concerned in Annex I to Decision 2005/217/EC.

(4) The signature and the stamp must be in a colour different to that of printing.

(5) Semen collection and storage centres approved in accordance with EC legislation are listed in the Commission’s website http://europa.eu.int/comm/food/index_en.htm

Note: This certificate must:

(a) be drawn up in at least one of the official languages of the Member State of destination and the Member State where the embryos will enter Community territory;

(b) be made out to a single consignee;

(c) accompany the embryos in the original.

VETERINARY CERTIFICATE

Embryos of domestic animals of the bovine species for imports collected or produced before 1 January 2006

1. Country of provenance and competent authority

2. Health certificate No:

A. ORIGIN OF EMBRYOS

3. Approval number of the embryo collection team or embryo production team (1):

4. Name and address of the embryo collection team or embryo production team (1):

5. Name and address of the consignor

6. Country and place of loading

7. Means of transport

B. DESTINATION OF EMBRYOS

8. Member State of destination

9. Name and address of the consignee

C. IDENTIFICATION OF EMBRYOS

10.1. Identification mark of embryos (2)

10.2. Number of embryos

10.3. Produced embryos (1)

10.4. Date of collection or production

(a) Derived by in vitro fertilisation

(b) Subjected to penetration of zona pellucida

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

D. HEALTH INFORMATION

11. I, the undersigned official veterinarian of the Government of

(insert name of exporting country)

certify that:

11.1. the embryo collection (1) production (1) team identified above:

is approved in accordance with Chapter I of Annex A to Directive 89/556/EEC,

carried out the collection, processing, production (1) and storing and transport of the embryos described above in accordance with Chapter II of Annex A to Directive 89/556/EEC,

is subjected at least twice per year to inspection by an official veterinarian.

11.2. The embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings:

11.2.1. has been free from rinderpest during 12 months immediately prior to the collection (1) or production (1) of the embryos;

11.2.2.1. either has been free from foot-and-mouth disease during the 12 months immediately prior to collection (1) or production (1) of the embryos and has not practised vaccination against foot-and-mouth disease during this period (1),

or

11.2.2.2. has not been free from foot-and-mouth disease for the 12 months immediately prior to the collection (1) or production (1) of the embryos and/or has practised vaccination against foot-and-mouth disease during this period, and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos come from a holding in which no animal has shown clinical signs of foot-and-mouth disease nor was vaccinated against foot-and-mouth disease during the 30 days prior to collection (1);

11.2.3.1. either has been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection (1) or production (1) of the embryos to be exported and has not practiced vaccination against these diseases during this period (1),

or

11.2.3.2. has not been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection (1) or production (1) of the embryos to be exported and/or has practised vaccination against these diseases during this period, and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to an agar gel immuno-diffusion test and a serum neutralisation test for the detection of antibodies against the epizootic haemorrhagic disease virus carried out with negative results on a blood sample taken not less than 21 days following collection (1);

11.3.

11.3.1. the premises on which the embryos to be exported or the ovaries, oocytes and other tissues used in the production of embryos to be exported were collected and processed were at the time of collection situated in the centre of an area of 20 km diameter in which according to official findings there had been no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis , Rift Valley fever or contagious bovine pleuropneumonia for 30 days immediately prior to collection and in the case of embryos certified under 11.2.2.2 and 11.2.3.2 for 30 days after collection;

11.3.2. between the time of collection or production of the embryos to be exported and their dispatch, they were stored continuously in approved premises which were situated in the centre of an area of 20 km in diameter in which according to official findings there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever;

11.4. the donor females and donors of ovaries, oocytes and other tissues used in the production of embryos:

11.4.1 were located during the 30 days immediately prior to collection of the embryos to be exported in premises situated in the centre of an area of 20 km in diameter in which according to official findings there was during this period no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia

11.4.2. showed no clinical sign of disease on the day of collection;

11.4.3. have spent the six months immediately prior to collection in the territory of the exporting country in a maximum of two herds:

which, according to official findings, have been free from tuberculosis,

which, according to official findings, have been free from brucellosis,

which have been free from enzootic bovine leukosis or in which no bovine animal has shown clinical signs of enzootic bovine leukosis during the previous three years,

in which no bovine animal has shown clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months.

11.5. The embryos comply with the following additional guarantees (3):

11.5.1. either the embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings is free of Akabane disease (1),

or

11.5.2. the embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings is not free of Akabane disease, and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to a serum neutralisation test for Akabane disease carried out with negative results on a blood sample taken not less than 21 days following collection (1).

11.6. The embryos to be exported were conceived as a result of artificial insemination or in vitro fertilisation with semen from a donor sire standing at a semen collection centre approved by the competent authority for the collection, processing and storage of semen or with semen imported from the European Community.

E. VALIDITY

12. Date and place

13. Name and qualification of the official veterinarian

14. Signature and stamp of the official veterinarian (4)

Note for guidance:

(1) Delete as appropriate.

(2) Corresponding to the identification of the donor cows and date of collection.

(3) See the remarks for the exporting country concerned in Annex I to Decision 2005/217/EC.

(4) The signature and the stamp must be in a colour different to that of printing.

Note: This certificate must:

(a) be drawn up in at least one of the official languages of the Member State of destination and the Member State where the embryos will enter Community territory;

(b) be made out to a single consignee;

(c) accompany the embryos in the original;

(d) not to be used after the date indicated in Article 3 of Decision 2005/217/EC.

Information: In accordance with Article 3(a) of Council Directive 89/556/EEC, embryos imported under the conditions laid down in this certificate are not eligible for intra-Community trade.